SSS 41
Alternative Names: SSS-41; SSS41-CAR-TLatest Information Update: 07 Feb 2025
At a glance
- Originator 3SBio
- Class Antineoplastics; CAR-T cell therapies; Gene therapies
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 17 Oct 2024 Preclinical trials in Cancer in China (Parenteral) (3sBio Pipeline, October 2024)